The figures in the accounts are merely accounting - cost of asset depreciated by some formula. I suspect that the figure arises from the accounting of the takeover of Inversion. Whatever the origin, it is practically meaningless. The value of the asset is what someone will pay, and that is entirely dependant on factors such as clinical results and market possibilities and potential competitors. The accounting value will not figure in the offer price from a potential counter party.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
12.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $10.59M | |||
| Open | High | Low | Value | Volume |
| 13.0¢ | 13.5¢ | 12.5¢ | $15.62K | 118.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 213400 | 12.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.5¢ | 57707 | 2 |
View Market Depth
| Last trade - 14.46pm 20/06/2025 (20 minute delay) ? |
| IVX (ASX) Chart |